Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Interest Coverage Ratio: 2009-2025

Historic Interest Coverage Ratio for Aytu Biopharma (AYTU) over the last 13 years, with Sep 2025 value amounting to -2.91.

  • Aytu Biopharma's Interest Coverage Ratio fell 211.53% to -2.91 in Q3 2025 from the same period last year, while for Sep 2025 it was -2.60, marking a year-over-year decrease of 454.22%. This contributed to the annual value of -2.11 for FY2025, which is 390.74% down from last year.
  • As of Q3 2025, Aytu Biopharma's Interest Coverage Ratio stood at -2.91, which was up 72.09% from -10.44 recorded in Q2 2025.
  • Aytu Biopharma's Interest Coverage Ratio's 5-year high stood at 2.69 during Q1 2025, with a 5-year trough of -10.44 in Q2 2025.
  • Over the past 3 years, Aytu Biopharma's median Interest Coverage Ratio value was -1.27 (recorded in 2024), while the average stood at -1.66.
  • Over the last 5 years, Aytu Biopharma's Interest Coverage Ratio had its largest YoY gain of 311.73% in 2025, and its largest YoY loss of 357.34% in 2025.
  • Quarterly analysis of 3 years shows Aytu Biopharma's Interest Coverage Ratio stood at 2.48 in 2023, then slumped by 163.22% to -1.57 in 2024, then crashed by 211.53% to -2.91 in 2025.
  • Its last three reported values are -2.91 in Q3 2025, -10.44 for Q2 2025, and 2.69 during Q1 2025.